Unplanned readmissions after Impella mechanical circulatory support.

Area of Science:

• Cardiology
• Medical Devices
• Health Services Research

Background:

• Early readmissions pose significant challenges to patient well-being and healthcare systems.
• Data on 30-day readmission rates following Impella mechanical circulatory support (MCS) were previously unknown.
• Understanding these readmissions is crucial for quality improvement in cardiovascular care.

Purpose of the Study:

• To assess the incidence, causes, and clinical outcomes of 30-day unplanned readmissions after Impella MCS.
• To identify patient and hospitalization factors associated with these readmissions.
• To evaluate the impact of readmission destination on patient mortality.

Main Methods:

• Analysis of the U.S. Nationwide Readmission Database from 2016-2019.
• Inclusion of patients discharged after Impella MCS implantation.
• Assessment of readmission rates, causes, and associated outcomes within 30 days.

Main Results:

• 12.2% of 22,055 patients experienced 30-day readmissions after Impella MCS.
• Heart failure (25%) and infections were leading causes of cardiac and non-cardiac readmissions, respectively.
• Older age, female sex, and comorbidities like renal, pulmonary, and liver disease were associated with higher readmission risk.

Conclusions:

• 30-day readmissions post-Impella MCS are common and influenced by patient demographics, comorbidities, and index hospitalization characteristics.
• Readmission to a hospital different from the implanting facility was associated with significantly higher mortality rates.
• Targeted interventions addressing heart failure and infections may reduce readmissions and improve outcomes for Impella MCS patients.